patent/WO-02069883-A3

http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-02069883-A3

Outgoing Links

Predicate	Object
assignee	http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c6c0e7f4cda96d5838728777a447d4e6 http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f0752ae37470d38fb00b638f45de8f59
classificationCPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-353
classificationIPCInventive	http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P13-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-353 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P19-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P11-00
filingDate	2002-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor	http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ec4b942c12d6fa2308bee7f4184022f9
publicationDate	2004-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber	WO-02069883-A3
titleOfInvention	Cathecin derivatives as leukocyte elastase inhibitors for treating inflammatory disorders
abstract	The present invention is directed to a method for treatment of inflammatory disorders by inhibiting leukocyte elastase in a host in need thereof. The method includes the step of administering an effective amount of catechin, such as epigallocatechin-3-gallate or epigallocatechin, in pure form or in a pharmaceutically acceptable carrier. The catechin can be administered orally, topically, by injection, or by inhalation.
priorityDate	2001-02-06-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type	http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate	Subject
isCitedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-0742012-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5376653-A http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-0074662-A2 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-5922756-A
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409163 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9064 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1203 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID72277 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409405 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID226409275

Total number of triples: 36.